Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Change in Account Payables (2020)

Insight Molecular Diagnostics' Change in Account Payables history spans 1 years, with the latest figure at -$6000.0 for Q1 2020.

  • For Q1 2020, Change in Account Payables changed N/A year-over-year to -$6000.0; the TTM value through Dec 2020 reached -$6000.0, changed N/A, while the annual FY2020 figure was -$6000.0, 99.71% up from the prior year.
  • Change in Account Payables for Q1 2020 was -$6000.0 at Insight Molecular Diagnostics.
  • Across five years, Change in Account Payables topped out at -$6000.0 in Q1 2020 and bottomed at -$6000.0 in Q1 2020.